Physician profile
Anthony Esposito
NPI 1548375876
$6,938.29
in general payments reported to CMS, 2019-2025
35 companies · $1,351 in 2025
The $1,351 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $467 · 2021: $865 · 2022: $919 · 2023: $1,286 · 2024: $1,381 · 2025: $1,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,017.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,593.66 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,112.64 | 2019-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $496.74 | 2019-2025 | |
| Lilly USA, LLC | $392.20 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $386.67 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $289.70 | 2021-2025 | Leqvio |
| Astrazeneca Pharmaceuticals LP | $252.71 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amarin Pharma, INC. | $232.13 | 2019-2022 | |
| Dexcom, INC. | $225.28 | 2021-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $206.76 | 2022-2025 | |
| Glaxosmithkline, LLC. | $188.62 | 2019-2024 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $170.79 | 2019-2025 | |
| Exact Sciences Corporation | $154.03 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.50 | 2021-2025 | Jardiance |
| Stryker Corporation | $134.72 | 2022 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Esposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.